» Articles » PMID: 12591009

Effects of Sphingosine-1-phosphate and Lysophosphatidic Acid on Human Osteoblastic Cells

Overview
Specialty Endocrinology
Date 2003 Feb 20
PMID 12591009
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of the lysophospholipids, sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA) were studied in human primary osteoblastic cells and the human osteosarcomal cell lines, G292 and MG-63. The studies focused on the role of the Gi protein in the regulation of S1P and LPA-induced proliferation, the effects of the phospholipids on alkaline phosphatase, an early marker of osteoblastic cell proliferation, and the presence of edg receptors. Proliferation was assessed by 3H-thymidine incorporation. Short-term incubation with S1P or LPA induced increases in proliferation that were attenuated in the presence of the Gi inhibitor, pertussis toxin. Alkaline phosphatase activity was measured with a spectrophotometric assay. Biphasic effects of S1P and LPA were observed with the nature of the response dependent upon the cell type, concentration of test agent and the time period of incubation. RTPCR studies revealed that edg-1,2,4,5 receptors are present in the primary normal osteoblastic cells, the MG63 and G292 cells. Only the G292 cells expressed the edg-3 receptor to any significant extent.

Citing Articles

Sphingolipid-Induced Bone Regulation and Its Emerging Role in Dysfunction Due to Disease and Infection.

Seal A, Hughes M, Wei F, Pugazhendhi A, Ngo C, Ruiz J Int J Mol Sci. 2024; 25(5).

PMID: 38474268 PMC: 10932382. DOI: 10.3390/ijms25053024.


The role of sphingosine-1-phosphate in bone remodeling and osteoporosis.

Grewe J, Knapstein P, Donat A, Jiang S, Smit D, Xie W Bone Res. 2022; 10(1):34.

PMID: 35396384 PMC: 8993882. DOI: 10.1038/s41413-022-00205-0.


Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner.

Liu H, Jackson M, Goudswaard L, Moore S, Hutchinson J, Hers I Sci Rep. 2021; 11(1):15308.

PMID: 34321503 PMC: 8319165. DOI: 10.1038/s41598-021-94052-4.


Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo.

Yu Z, Jiao B, Li Z Biomed Res Int. 2018; 2018:7537630.

PMID: 30003106 PMC: 5996417. DOI: 10.1155/2018/7537630.


Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Sartawi Z, Schipani E, Ryan K, Waeber C Pharmacol Res. 2017; 125(Pt B):232-245.

PMID: 28855094 PMC: 7253298. DOI: 10.1016/j.phrs.2017.08.013.